{
  "id": "new-onset-seizure",
  "title": "New Onset Seizure",
  "version": "1.2",
  "icd10": [
    "** R56.9 (Unspecified convulsions)",
    "G40.909 (Epilepsy",
    "unspecified",
    "not intractable",
    "without status epilepticus)"
  ],
  "scope": "** Initial evaluation and management of first-time unprovoked seizure or first presentation of seizure activity in adults. Covers immediate stabilization, diagnostic workup to identify etiology, acute treatment, and framework for anti-seizure medication (ASM) initiation. Excludes status epilepticus (see \"Status Epilepticus\" template), pediatric seizures, febrile seizures, and known epilepsy with breakthrough seizures.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "Point-of-care glucose",
          "rationale": "Hypoglycemia is immediately reversible cause",
          "target": ">70 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "CBC with differential",
          "rationale": "Infection screen, baseline before ASMs",
          "target": "Normal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "CMP (BMP + LFTs)",
          "rationale": "Electrolyte abnormalities (Na, Ca, Mg, glucose), renal/hepatic function for ASM dosing",
          "target": "Normal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Magnesium",
          "rationale": "Hypomagnesemia lowers seizure threshold",
          "target": ">1.8 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Calcium (ionized if available)",
          "rationale": "Hypocalcemia can cause seizures",
          "target": "Normal (ionized 4.5-5.3 mg/dL)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Urine drug screen",
          "rationale": "Illicit drugs (cocaine, amphetamines) and withdrawal states",
          "target": "Negative",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Blood alcohol level",
          "rationale": "Alcohol intoxication or withdrawal",
          "target": "Correlate with history",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Urinalysis",
          "rationale": "UTI can provoke seizures (especially elderly)",
          "target": "Negative",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Prolactin level",
          "rationale": "Elevated if drawn within 10-20 min of event; helps distinguish seizure from non-epileptic event",
          "target": "Elevated 2-3× baseline (if drawn <20 min)",
          "ED": "STAT",
          "HOSP": "—",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Phosphorus",
          "rationale": "Hypophosphatemia lowers seizure threshold (especially alcohol withdrawal)",
          "target": ">2.5 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Lactate",
          "rationale": "Elevated post-ictal confirms recent seizure; metabolic acidosis screen",
          "target": "Mild elevation acceptable post-ictal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Extended Workup": [
        {
          "item": "TSH",
          "rationale": "Thyroid dysfunction can affect seizure threshold",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Ammonia",
          "rationale": "Hepatic encephalopathy, urea cycle disorders",
          "target": "Normal (<35 μmol/L)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Troponin",
          "rationale": "Cardiac ischemia as cause or consequence",
          "target": "Negative",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "ECG",
          "rationale": "Arrhythmia, prolonged QTc (some ASMs), Brugada",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Blood gas (ABG or VBG)",
          "rationale": "Acidosis, hypoxia",
          "target": "Normal or mild post-ictal acidosis",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Serum osmolality",
          "rationale": "Hypo/hyperosmolar states",
          "target": "280-295 mOsm/kg",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Pregnancy test (urine or serum β-hCG)",
          "rationale": "Eclampsia; affects imaging and ASM choice",
          "target": "Negative (or explains eclampsia if positive)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "B12 level",
          "rationale": "Deficiency associated with seizures",
          "target": "Normal (>300 pg/mL)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Folate level",
          "rationale": "Deficiency can lower threshold; important for women of childbearing potential",
          "target": "Normal",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Serum/urine toxicology (expanded panel)",
          "rationale": "Synthetic drugs, medications not on standard screen",
          "target": "Negative",
          "ED": "URGENT",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "URGENT"
        },
        {
          "item": "Heavy metals (lead, mercury)",
          "rationale": "Occupational exposure, pica",
          "target": "Normal",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Ceruloplasmin, serum copper",
          "rationale": "Wilson disease (young patients)",
          "target": "Normal",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "HIV",
          "rationale": "HIV-associated CNS disease",
          "target": "Negative",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "RPR/VDRL",
          "rationale": "Neurosyphilis",
          "target": "Negative",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Autoimmune encephalitis panel (serum)",
          "rationale": "Anti-NMDAR, LGI1, CASPR2, GABA-B if clinical suspicion",
          "target": "Negative",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Paraneoplastic panel (serum)",
          "rationale": "Subacute onset, smoking, weight loss",
          "target": "Negative",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Porphyrins (urine/serum)",
          "rationale": "Acute intermittent porphyria",
          "target": "Normal",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Genetic epilepsy panel",
          "rationale": "Young onset, family history, refractory",
          "target": "Variable",
          "ED": "—",
          "HOSP": "—",
          "OPD": "EXT",
          "ICU": "—"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "CT head without contrast",
          "timing": "Immediate in ED",
          "target": "Mass, hemorrhage, stroke, calcification, hydrocephalus",
          "contraindications": "Pregnancy (relative - benefit usually outweighs risk)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "MRI brain with and without contrast (epilepsy protocol)*",
          "timing": "Within 24-48h if inpatient; within 2 weeks if outpatient",
          "target": "Tumor, mesial temporal sclerosis, cortical dysplasia, encephalitis, stroke, vascular malformation",
          "contraindications": "GFR <30, gadolinium allergy, pacemaker",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "EEG (routine)",
          "timing": "Within 24h if possible; ideally within 24-48h of seizure",
          "target": "Epileptiform discharges (spikes, sharp waves), focal slowing",
          "contraindications": "None significant",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        }
      ],
      "Extended": [
        {
          "item": "Continuous EEG (cEEG) monitoring",
          "timing": "If altered mental status persists, suspected non-convulsive status",
          "target": "Non-convulsive seizures, non-convulsive status epilepticus",
          "contraindications": "None significant",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Prolonged ambulatory EEG (24-72h)",
          "timing": "Outpatient if routine EEG non-diagnostic",
          "target": "Capture interictal or ictal activity",
          "contraindications": "None significant",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Video-EEG monitoring",
          "timing": "If diagnosis uncertain (vs. psychogenic)",
          "target": "Correlate clinical events with EEG",
          "contraindications": "None significant",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "MRA/MRV brain",
          "timing": "If vascular etiology suspected",
          "target": "AVM, aneurysm, venous thrombosis",
          "contraindications": "Same as MRI",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "CT angiography head",
          "timing": "If MRA unavailable and vascular cause suspected",
          "target": "Vascular malformation, aneurysm",
          "contraindications": "Contrast allergy, renal insufficiency",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Echocardiogram",
          "timing": "If embolic stroke suspected as cause",
          "target": "Thrombus, PFO, vegetation",
          "contraindications": "None significant",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Chest X-ray",
          "timing": "Aspiration risk post-ictal, lung cancer screening if paraneoplastic suspected",
          "target": "Clear lungs or mass",
          "contraindications": "None significant",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "PET-CT brain (interictal FDG)",
          "timing": "Epilepsy surgery workup",
          "target": "Focal hypometabolism",
          "contraindications": "Pregnancy, uncontrolled diabetes",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "SPECT (ictal/interictal)",
          "timing": "Epilepsy surgery workup",
          "target": "Ictal hyperperfusion",
          "contraindications": "Requires seizure capture",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "MEG (magnetoencephalography)",
          "timing": "Epilepsy surgery workup",
          "target": "Localize epileptogenic focus",
          "contraindications": "Metallic implants",
          "ED": "—",
          "HOSP": "—",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Neuropsychological testing",
          "timing": "Pre-surgical evaluation, cognitive concerns",
          "target": "Lateralizing deficits",
          "contraindications": "Patient cooperation",
          "ED": "—",
          "HOSP": "—",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Wada test (intracarotid amobarbital)",
          "timing": "Pre-surgical language/memory lateralization",
          "target": "Language and memory dominance",
          "contraindications": "Contrast allergy, vascular anomaly",
          "ED": "—",
          "HOSP": "—",
          "OPD": "EXT",
          "ICU": "—"
        }
      ]
    },
    "Lumbar Puncture": {
      "Studies": [
        {
          "item": "Opening pressure",
          "rationale": "Elevated ICP, mass effect",
          "target": "10-20 cm H2O",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Cell count (tubes 1 and 4)",
          "rationale": "Infection, inflammation",
          "target": "WBC <5; RBC 0",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Protein",
          "rationale": "Elevated in infection, inflammation",
          "target": "15-45 mg/dL",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Glucose with serum glucose",
          "rationale": "Low in bacterial/fungal/TB meningitis",
          "target": ">60% serum",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Gram stain and culture",
          "rationale": "Bacterial meningitis",
          "target": "No organisms",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "BioFire FilmArray ME Panel",
          "rationale": "Rapid pathogen identification (14 pathogens)",
          "target": "Negative",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "HSV-1/2 PCR",
          "rationale": "HSV encephalitis (most common treatable cause)",
          "target": "Negative",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Autoimmune encephalitis panel (CSF)",
          "rationale": "If clinical suspicion for autoimmune etiology",
          "target": "Negative",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Cytology",
          "rationale": "Carcinomatous meningitis",
          "target": "Negative",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "VDRL (CSF)",
          "rationale": "Neurosyphilis",
          "target": "Negative",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Oligoclonal bands",
          "rationale": "If demyelinating disease suspected",
          "target": "Negative or matched with serum",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "Lorazepam IV/IM (if actively seizing)",
          "dosing": "0.1 mg/kg IV (max 4 mg); may repeat once in 5 min",
          "contraindications": "Respiratory depression, severe hypotension",
          "monitoring": "RR, O2 sat, BP; have airway equipment ready",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Midazolam IM (if no IV access)",
          "dosing": "10 mg IM (if >40 kg) or 0.2 mg/kg IM",
          "contraindications": "Respiratory depression",
          "monitoring": "RR, O2 sat; have airway equipment ready",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Midazolam intranasal (if no IV access)",
          "dosing": "5 mg per nostril (total 10 mg)",
          "contraindications": "Respiratory depression",
          "monitoring": "RR, O2 sat",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Dextrose 50% IV",
          "dosing": "25-50 mL IV if hypoglycemia confirmed or suspected",
          "contraindications": "Hyperglycemia",
          "monitoring": "Glucose",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Thiamine IV",
          "dosing": "100-500 mg IV BEFORE glucose if alcohol use suspected",
          "contraindications": "None significant",
          "monitoring": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Supplemental oxygen",
          "dosing": "2-4 L NC or non-rebreather as needed",
          "contraindications": "None",
          "monitoring": "O2 sat >94%",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "IV fluids (isotonic)",
          "dosing": "NS or LR bolus if hypotensive; maintenance if euvolemic",
          "contraindications": "Fluid overload, severe hyponatremia",
          "monitoring": "I/O, BP, Na",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Flumazenil (rescue only)",
          "dosing": "0.2 mg IV over 30 sec; may repeat 0.2 mg q1min to max 1 mg",
          "contraindications": "Chronic benzodiazepine use; seizure history; tricyclic overdose",
          "monitoring": "**CAUTION:** May lower seizure threshold and precipitate seizures; use only if severe respiratory depression unresponsive to supportive care",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Anti-Seizure Medications (ASMs) - Acute Loading": [
        {
          "item": "Levetiracetam IV",
          "indication": "First-line acute loading",
          "dosing": "40-60 mg/kg IV (max 4500 mg) over 15 min; OR 1500-3000 mg IV",
          "contraindications": "None significant; reduce dose if CrCl <50",
          "monitoring": "Somnolence, agitation (rare)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Levetiracetam PO",
          "indication": "Acute loading if stable",
          "dosing": "1500-3000 mg PO × 1, then start maintenance",
          "contraindications": "Same",
          "monitoring": "Same",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "URGENT",
          "ICU": "—"
        },
        {
          "item": "Fosphenytoin IV",
          "indication": "Alternative first-line",
          "dosing": "20 mg PE/kg IV at 150 mg PE/min (max rate)",
          "contraindications": "AV block, sinus bradycardia, pregnancy (relative)",
          "monitoring": "Continuous cardiac monitoring, BP; purple glove syndrome rare with fosphenytoin",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Phenytoin IV",
          "indication": "If fosphenytoin unavailable",
          "dosing": "20 mg/kg IV at max 50 mg/min",
          "contraindications": "AV block, sinus bradycardia, pregnancy",
          "monitoring": "Cardiac monitor, BP; give via large vein (tissue necrosis risk)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Valproate IV",
          "indication": "Alternative (broad-spectrum)",
          "dosing": "40 mg/kg IV over 10 min (max 3000 mg)",
          "contraindications": "Pregnancy (teratogenic - neural tube defects), hepatic disease, mitochondrial disease, urea cycle disorders",
          "monitoring": "LFTs, ammonia, platelets; pancreatitis risk",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Lacosamide IV",
          "indication": "Alternative first-line",
          "dosing": "200-400 mg IV over 15-30 min",
          "contraindications": "PR prolongation >200 ms, 2nd/3rd degree AV block",
          "monitoring": "ECG for PR interval; dizziness",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        }
      ],
      "Anti-Seizure Medications (ASMs) - Maintenance Therapy": [
        {
          "item": "Levetiracetam",
          "indication": "First-line maintenance",
          "dosing": "500-1500 mg PO/IV BID; start 500 mg BID, may increase by 500 mg/dose weekly; max 3000 mg/day",
          "contraindications": "Renal impairment (adjust per CrCl)",
          "monitoring": "Behavioral changes (irritability, depression - \"Keppra rage\"); renal function",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Lamotrigine",
          "indication": "First-line (especially women of childbearing potential)",
          "dosing": "Start 25 mg daily × 2 weeks; then 50 mg daily × 2 weeks; then 100 mg daily; target 200-400 mg/day in divided doses",
          "contraindications": "Slow titration required (SJS/TEN risk)",
          "monitoring": "Rash (stop if any rash; SJS/TEN risk higher with fast titration or valproate co-therapy)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Lacosamide",
          "indication": "First-line alternative",
          "dosing": "Start 100 mg PO BID; increase by 100 mg/day weekly; target 200-400 mg BID; max 400 mg BID",
          "contraindications": "PR prolongation, 2nd/3rd degree AV block, severe hepatic impairment",
          "monitoring": "ECG at baseline and dose changes; dizziness, diplopia",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Oxcarbazepine",
          "indication": "Focal seizures",
          "dosing": "Start 300 mg PO BID; increase by 300-600 mg/day every week; target 1200-2400 mg/day in divided doses",
          "contraindications": "Hypersensitivity to carbamazepine",
          "monitoring": "Sodium (hyponatremia in 2-3%); HLA-B*1502 screening in at-risk populations",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Carbamazepine",
          "indication": "Focal seizures",
          "dosing": "Start 200 mg PO BID; increase by 200 mg/day weekly; target 800-1200 mg/day; max 1600 mg/day",
          "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
          "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Valproate/Divalproex",
          "indication": "Generalized seizures",
          "dosing": "Start 10-15 mg/kg/day in divided doses; increase by 5-10 mg/kg/week; target 1000-2000 mg/day; max 60 mg/kg/day",
          "contraindications": "Pregnancy (teratogenic); hepatic disease; mitochondrial disease; pancreatitis history",
          "monitoring": "LFTs, ammonia, CBC, platelets at baseline, then q3-6mo; weight gain, hair loss, tremor",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Phenytoin",
          "indication": "Focal or generalized",
          "dosing": "300-400 mg daily (extended release) or divided TID (immediate release); adjust by level",
          "contraindications": "Pregnancy (relative - fetal hydantoin syndrome); AV block",
          "monitoring": "Free phenytoin level (target 1-2 μg/mL); total level 10-20 μg/mL; CBC, LFTs; gingival hyperplasia, hirsutism",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Brivaracetam",
          "indication": "Alternative to levetiracetam",
          "dosing": "Start 50 mg PO BID; may increase to 100 mg BID; max 200 mg/day",
          "contraindications": "Hepatic impairment (reduce dose)",
          "monitoring": "Less behavioral side effects than levetiracetam; somnolence; Schedule C-V",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Zonisamide",
          "indication": "Adjunctive or monotherapy",
          "dosing": "Start 100 mg daily; increase by 100 mg every 2 weeks; target 300-400 mg daily; max 600 mg/day",
          "contraindications": "Sulfonamide allergy; kidney stones",
          "monitoring": "Kidney stones (carbonic anhydrase inhibitor); oligohidrosis (pediatric); metabolic acidosis",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Topiramate",
          "indication": "Adjunctive or monotherapy",
          "dosing": "Start 25 mg BID; increase by 50 mg/day weekly; target 200-400 mg/day in divided doses; max 400 mg/day",
          "contraindications": "Kidney stones; metabolic acidosis; glaucoma",
          "monitoring": "Cognitive impairment (\"dopamax\"); paresthesias; kidney stones; weight loss",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Clobazam",
          "indication": "Adjunctive therapy",
          "dosing": "Start 5-10 mg daily; increase by 5-10 mg weekly; max 40 mg/day in divided doses",
          "contraindications": "Severe hepatic impairment; sleep apnea (untreated)",
          "monitoring": "Sedation; tolerance may develop; CYP2C19 poor metabolizers need lower dose",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Perampanel",
          "indication": "Adjunctive for focal or GTCS",
          "dosing": "Start 2 mg qHS; increase by 2 mg weekly; target 8-12 mg qHS; max 12 mg/day",
          "contraindications": "None absolute",
          "monitoring": "Psychiatric effects (aggression, hostility); dizziness; take at bedtime; Schedule III",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Cenobamate",
          "indication": "Adjunctive for focal",
          "dosing": "Start 12.5 mg daily × 2 weeks; titrate slowly per package insert; target 200-400 mg daily",
          "contraindications": "Familial short QT syndrome",
          "monitoring": "Very slow titration required (DRESS risk); QT shortening; titration pack available",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Phenobarbital",
          "indication": "Refractory or resource-limited",
          "dosing": "Load 15-20 mg/kg IV; maintenance 1-3 mg/kg/day (60-180 mg/day); target level 15-40 μg/mL",
          "contraindications": "Porphyria; severe respiratory disease",
          "monitoring": "Sedation; cognitive effects; drug interactions (CYP inducer); level monitoring",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        }
      ],
      "Symptomatic Treatments": [
        {
          "item": "Acetaminophen",
          "indication": "Post-ictal headache",
          "dosing": "650-1000 mg PO/IV q6h PRN; max 3000 mg/day (2000 mg if liver disease)",
          "contraindications": "Severe hepatic impairment",
          "monitoring": "LFTs if chronic use",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Ibuprofen",
          "indication": "Post-ictal headache",
          "dosing": "400-600 mg PO q6-8h PRN; max 2400 mg/day",
          "contraindications": "Renal impairment; GI bleed; post-CABG",
          "monitoring": "Renal function if prolonged use",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Ondansetron",
          "indication": "Post-ictal nausea",
          "dosing": "4-8 mg IV/PO q8h PRN",
          "contraindications": "QT prolongation; severe hepatic impairment",
          "monitoring": "QTc if multiple doses",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Lorazepam",
          "indication": "Post-ictal agitation (if severe)",
          "dosing": "0.5-2 mg IV/PO PRN; use with caution",
          "contraindications": "Respiratory depression; altered mental status",
          "monitoring": "RR, sedation level; avoid if post-ictal confusion resolving",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Sertraline",
          "indication": "Depression/anxiety (chronic)",
          "dosing": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
          "contraindications": "Concurrent MAOIs",
          "monitoring": "Suicidality monitoring weeks 1-4",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Escitalopram",
          "indication": "Depression/anxiety (chronic)",
          "dosing": "Start 10 mg daily; max 20 mg daily",
          "contraindications": "Concurrent MAOIs; QT prolongation",
          "monitoring": "QTc if risk factors",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Melatonin",
          "indication": "Sleep disturbance",
          "dosing": "3-5 mg PO qHS",
          "contraindications": "None significant",
          "monitoring": "Well tolerated; may help with ASM-related sleep disruption",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Trazodone",
          "indication": "Insomnia",
          "dosing": "25-100 mg PO qHS",
          "contraindications": "Concurrent MAOIs",
          "monitoring": "Orthostatic hypotension; priapism (rare)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        }
      ],
      "Second-line/Refractory": [
        {
          "item": "Add second ASM",
          "dosing": "Choose complementary mechanism; see maintenance options",
          "contraindications": "Per specific agent",
          "monitoring": "Per specific agent",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Epilepsy surgery evaluation referral",
          "dosing": "For drug-resistant epilepsy (failed 2+ appropriately chosen ASMs)",
          "contraindications": "N/A",
          "monitoring": "N/A",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Vagus nerve stimulator (VNS)",
          "dosing": "For drug-resistant epilepsy not surgical candidates",
          "contraindications": "N/A",
          "monitoring": "Device checks",
          "ED": "—",
          "HOSP": "—",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Dietary therapy (ketogenic diet, modified Atkins)",
          "dosing": "For drug-resistant epilepsy",
          "contraindications": "Fatty acid oxidation disorders; pyruvate carboxylase deficiency",
          "monitoring": "Metabolic panels; lipids; kidney function",
          "ED": "—",
          "HOSP": "—",
          "OPD": "EXT",
          "ICU": "—"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology consult",
          "indication": "All new onset seizures for evaluation and management",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Epilepsy specialist referral",
          "indication": "Diagnostic uncertainty, refractory seizures, surgical candidacy",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "EEG technologist/neurodiagnostics",
          "indication": "EEG scheduling; continuous EEG if indicated",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Neurosurgery consult",
          "indication": "Structural lesion requiring intervention (tumor, AVM, SDH)",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "EXT",
          "ICU": "URGENT"
        },
        {
          "item": "Medical toxicology consult",
          "indication": "Suspected drug/toxin-induced seizure",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Infectious disease consult",
          "indication": "CNS infection confirmed or suspected",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Oncology consult",
          "indication": "Brain tumor identified",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Psychiatry consult",
          "indication": "Depression, anxiety post-diagnosis; psychogenic non-epileptic spells suspected",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Social work consult",
          "indication": "Driving restrictions impact, employment concerns, insurance navigation",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Occupational therapy",
          "indication": "Work safety evaluation, activity modification",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Physical therapy",
          "indication": "If post-ictal weakness, falls, injury from seizure",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Neuropsychology referral",
          "indication": "Cognitive complaints, pre-surgical evaluation",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Women's health/OB-GYN",
          "indication": "Contraception counseling (ASM interactions), pregnancy planning",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Epilepsy monitoring unit (EMU) admission",
          "indication": "Characterize seizure type, video-EEG monitoring, pre-surgical evaluation",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "—"
        },
        {
          "item": "Driving evaluation/rehabilitation",
          "indication": "Return to driving assessment when eligible",
          "ED": "—",
          "HOSP": "—",
          "OPD": "EXT",
          "ICU": "—"
        }
      ],
      "Patient Instructions": [
        {
          "item": "**Return to ED immediately if:** recurrent seizure, prolonged seizure >5 minutes, head injury, persistent confusion, difficulty breathing, or status epilepticus",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Do NOT drive until cleared by neurology (driving restrictions per state guidelines; typically require seizure-free interval)",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Avoid operating heavy machinery, working at heights, or swimming alone",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Do not bathe alone; showers preferred over baths; keep bathroom door unlocked",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Inform employer if job involves safety-sensitive duties",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Take ASM exactly as prescribed; do NOT stop abruptly (risk of breakthrough seizures or status epilepticus)",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Avoid common seizure triggers: sleep deprivation, alcohol, illicit drugs, missed medications",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Keep a seizure diary: date, time, duration, description, triggers, post-ictal symptoms",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Wear medical identification (bracelet or necklace)",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Educate family/coworkers on seizure first aid: stay with person, protect head, do NOT put anything in mouth, time the seizure, call 911 if >5 minutes",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Follow up with neurology within 1-2 weeks of discharge",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "—",
          "ICU": "—"
        },
        {
          "item": "Bring list of all medications (including OTC and supplements) to all appointments - many interact with ASMs",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Women: discuss contraception with provider; some ASMs reduce efficacy of hormonal contraception",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Report side effects (mood changes, rash, dizziness, cognitive issues) promptly; do NOT stop medication without calling",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Avoid flashing/strobe lights if photosensitive seizures suspected",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Sleep hygiene: aim for 7-9 hours nightly; maintain regular sleep schedule",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Avoid alcohol (lowers seizure threshold; interacts with ASMs)",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Avoid illicit drugs (especially stimulants: cocaine, amphetamines)",
          "ED": "✓",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Stress management techniques",
          "ED": "—",
          "HOSP": "—",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Regular moderate exercise (not extreme sleep deprivation from overtraining)",
          "ED": "—",
          "HOSP": "—",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Medication adherence: use pill organizers, phone alarms, refill reminders",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Folic acid supplementation 1-4 mg daily for women of childbearing potential (especially if on enzyme-inducing ASMs)",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Bone health: vitamin D 1000-2000 IU daily; calcium as needed (enzyme-inducing ASMs affect bone density)",
          "ED": "—",
          "HOSP": "—",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Avoid known personal triggers (flashing lights, certain foods, stress, if identified)",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Home safety modifications: pad sharp furniture corners, avoid glass shower doors, use microwave instead of stovetop when alone",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Seizure alert devices or apps for those living alone (optional)",
          "ED": "—",
          "HOSP": "—",
          "OPD": "✓",
          "ICU": "—"
        },
        {
          "item": "Smoking cessation (increases ASM metabolism; general health)",
          "ED": "—",
          "HOSP": "✓",
          "OPD": "✓",
          "ICU": "—"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Syncope (convulsive syncope)",
      "features": "Brief (<15 sec), triggered by standing/Valsalva/micturition, rapid recovery, no post-ictal confusion, possible prodrome (lightheaded, tunnel vision)",
      "tests": "ECG, orthostatic vitals, tilt table test, echocardiogram"
    },
    {
      "diagnosis": "Psychogenic non-epileptic spells (PNES)",
      "features": "Variable/atypical semiology, prolonged duration, preserved awareness with bilateral movements, eye closure, pelvic thrusting, no post-ictal confusion, psychiatric comorbidity",
      "tests": "Video-EEG capturing event; normal prolactin"
    },
    {
      "diagnosis": "Transient ischemic attack (TIA)",
      "features": "Negative symptoms (weakness, numbness), no LOC, no convulsive activity",
      "tests": "MRI DWI, vascular imaging"
    },
    {
      "diagnosis": "Migraine with aura",
      "features": "Gradual onset, spreading symptoms, headache follows, stereotyped",
      "tests": "Clinical history, normal EEG"
    },
    {
      "diagnosis": "Hypoglycemia",
      "features": "Diaphoresis, tremor, confusion, rapid glucose corrects symptoms",
      "tests": "Fingerstick glucose"
    },
    {
      "diagnosis": "Cardiac arrhythmia",
      "features": "Palpitations, sudden LOC without warning, rapid recovery",
      "tests": "ECG, Holter monitor, event recorder, EP study"
    },
    {
      "diagnosis": "Transient global amnesia",
      "features": "Isolated anterograde amnesia, repetitive questioning, no convulsive activity",
      "tests": "Clinical presentation (self-limited), MRI DWI (hippocampal)"
    },
    {
      "diagnosis": "Sleep disorders (parasomnias, cataplexy)",
      "features": "Occur from sleep, specific features (cataplexy with emotion)",
      "tests": "Sleep study, clinical history"
    },
    {
      "diagnosis": "Movement disorders (dystonia, tics)",
      "features": "Stereotyped, no LOC, suppressible (tics), may have sensory urge",
      "tests": "Clinical history, video"
    },
    {
      "diagnosis": "Drug intoxication/withdrawal",
      "features": "History of substance use, known withdrawal timeline",
      "tests": "Toxicology screen, history"
    },
    {
      "diagnosis": "Metabolic encephalopathy",
      "features": "Gradual onset, diffuse abnormality, asterixis, no discrete seizures",
      "tests": "Labs (ammonia, glucose, Na), EEG (diffuse slowing)"
    }
  ],
  "evidence": [
    {
      "recommendation": "ILAE 2017 seizure classification",
      "evidenceLevel": "Class I",
      "source": "Fisher RS et al. Epilepsia 2017"
    },
    {
      "recommendation": "ILAE 2014 practical definition of epilepsy",
      "evidenceLevel": "Class I",
      "source": "Fisher RS et al. Epilepsia 2014"
    },
    {
      "recommendation": "EEG within 24-48h increases yield",
      "evidenceLevel": "Class II, Level B",
      "source": "AAN Practice Parameter 2007"
    },
    {
      "recommendation": "MRI superior to CT for epilepsy evaluation",
      "evidenceLevel": "Class I, Level A",
      "source": "ILAE Commission Report 2019"
    },
    {
      "recommendation": "Levetiracetam non-inferior to phenytoin for acute seizure cessation",
      "evidenceLevel": "Class I, Level A",
      "source": "ESETT Trial, NEJM 2019"
    },
    {
      "recommendation": "Risk of recurrence after first unprovoked seizure ~40-50%",
      "evidenceLevel": "Class I",
      "source": "Hauser et al., NEJM 1998"
    },
    {
      "recommendation": "Starting ASM after first seizure reduces recurrence but not long-term remission",
      "evidenceLevel": "Class I, Level A",
      "source": "FIRST and MESS trials"
    },
    {
      "recommendation": "Lamotrigine and levetiracetam preferred in women of childbearing potential",
      "evidenceLevel": "Class II, Level B",
      "source": "AAN/AES Guidelines 2009, MONEAD Study"
    },
    {
      "recommendation": "Driving restrictions reduce accident risk",
      "evidenceLevel": "Class II, Level B",
      "source": "Multiple observational studies"
    },
    {
      "recommendation": "Prolactin elevation supports diagnosis of epileptic seizure (if drawn <20 min)",
      "evidenceLevel": "Class II, Level B",
      "source": "Chen et al., Neurology 2005"
    },
    {
      "recommendation": "Continuous EEG detects non-convulsive status in altered patients",
      "evidenceLevel": "Class II, Level B",
      "source": "Claassen et al., Neurology 2004"
    },
    {
      "recommendation": "Folate supplementation reduces teratogenicity risk",
      "evidenceLevel": "Class II, Level B",
      "source": "AAN Practice Parameter"
    }
  ],
  "monitoring": [
    {
      "item": "Neurologic exam (level of consciousness, focal deficits)",
      "frequency": "Q1-2h in ED; Q4h inpatient; each visit OPD",
      "action": "If prolonged post-ictal state: continuous EEG to rule out non-convulsive status",
      "ED": "✓",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "✓"
    },
    {
      "item": "Vital signs",
      "frequency": "Continuous in ED/ICU; Q4h floor",
      "action": "Treat hyperthermia, hypotension, hypoxia",
      "ED": "✓",
      "HOSP": "✓",
      "OPD": "—",
      "ICU": "✓"
    },
    {
      "item": "Respiratory monitoring (post-benzodiazepine)",
      "frequency": "RR q15min × 1h post-administration; SpO2 continuous",
      "action": "Supplemental O2; airway management; consider flumazenil only if severe",
      "ED": "✓",
      "HOSP": "✓",
      "OPD": "—",
      "ICU": "✓"
    },
    {
      "item": "Glucose",
      "frequency": "On arrival; repeat if altered",
      "action": "Dextrose if low",
      "ED": "✓",
      "HOSP": "✓",
      "OPD": "—",
      "ICU": "✓"
    },
    {
      "item": "Electrolytes (Na, Ca, Mg)",
      "frequency": "On arrival; daily if abnormal",
      "action": "Correct deficiencies; identify cause",
      "ED": "✓",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "✓"
    },
    {
      "item": "ASM level (phenytoin, valproate, phenobarbital, carbamazepine)",
      "frequency": "Trough level 5-7 days after initiation or dose change; PRN",
      "action": "Adjust dose; check free level for phenytoin",
      "ED": "—",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "✓"
    },
    {
      "item": "LFTs",
      "frequency": "Baseline; q3-6 months on valproate, carbamazepine",
      "action": "Discontinue if hepatotoxicity; hold if transaminases >3× ULN",
      "ED": "—",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "✓"
    },
    {
      "item": "CBC",
      "frequency": "Baseline; q3-6 months on carbamazepine, valproate",
      "action": "Discontinue if significant bone marrow suppression",
      "ED": "—",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "✓"
    },
    {
      "item": "Sodium",
      "frequency": "Baseline; periodically on oxcarbazepine, carbamazepine",
      "action": "Reduce dose or switch if severe hyponatremia",
      "ED": "—",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "✓"
    },
    {
      "item": "EEG",
      "frequency": "Within 24-48h of first seizure; repeat if diagnosis unclear",
      "action": "Adjust treatment if epileptiform activity or non-convulsive seizures",
      "ED": "✓",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "✓"
    },
    {
      "item": "MRI brain",
      "frequency": "Within 2 weeks of first seizure; sooner if structural cause suspected",
      "action": "Address structural cause; refer to appropriate specialist",
      "ED": "—",
      "HOSP": "✓",
      "OPD": "✓",
      "ICU": "—"
    }
  ],
  "disposition": [
    {
      "disposition": "**Discharge home**",
      "criteria": "Single, self-limited seizure; returned to baseline; no dangerous etiology identified on initial workup; reliable adult supervision for 24h; ASM initiated or deferred with close follow-up; outpatient EEG and MRI arranged; understands return precautions and driving restriction"
    },
    {
      "disposition": "**Admit to floor (observation)**",
      "criteria": "Prolonged post-ictal period; multiple seizures; new structural lesion requiring monitoring; ASM loading requiring observation; social situation preventing safe discharge; need for inpatient EEG; new focal neurologic deficit"
    },
    {
      "disposition": "**Admit to ICU**",
      "criteria": "Status epilepticus (current or recent); recurrent seizures despite treatment; need for continuous EEG monitoring; airway compromise; hemodynamic instability; significant aspiration; large structural lesion with mass effect; CNS infection"
    },
    {
      "disposition": "**Transfer to higher level**",
      "criteria": "MRI unavailable; EEG unavailable; neurology not available for consultation; need for neurosurgical intervention unavailable at facility"
    }
  ]
}